Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Medicine, Baltimore, Maryland (G.C.A.).
Johns Hopkins University School of Medicine, Baltimore, Maryland (K.B.S.).
Ann Intern Med. 2020 Jul 7;173(1):57-58. doi: 10.7326/M20-1141. Epub 2020 Apr 2.
The COVID-19 pandemic is a particularly grave risk to the millions of Americans with opioid use disorder, who—already vulnerable and marginalized—are heavily dependent on face-to-face health care delivery. These authors propose rapid and coordinated action on the part of clinicians and policymakers to mitigate risks of disrupted care for these patients.
新冠疫情给数百万患有阿片类药物使用障碍的美国人带来了特别严重的风险，这些人已经很脆弱和边缘化，严重依赖面对面的医疗服务。作者们提议临床医生和政策制定者迅速采取协调行动，减轻这些患者护理中断的风险。
